{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:06:14Z","timestamp":1791295574893,"version":"4.1.0"},"reference-count":20,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Late-onset erythropoietic protoporphyria (EPP) is a rare complication of myelodysplastic syndrome (MDS) but has not been described in association with a myeloproliferative disorder (MPD). EPP is normally an inherited disorder characterized by photosensitivity that starts in early childhood and results from overproduction of protoporphyrin secondary to ferrochelatase (FECH) deficiency. Severe liver disease occurs in 1% to 2% of patients. Here we report that severe photosensitivity and cholestatic liver disease in a patient with a myeloproliferative disorder was caused by excess protoporphyrin production from a clone of hematopoietic cells in which one FECH allele had been deleted. Our observations suggest that the usual explanation for the association of late-onset EPP with MPD and MDS is acquired somatic mutation of one FECH allele in bone marrow and show for the first time that the consequent overproduction of protoporphyrin may be severe enough to cause acute liver damage.<\/jats:p>","DOI":"10.1182\/blood-2004-12-4939","type":"journal-article","created":{"date-parts":[[2005,9,9]],"date-time":"2005-09-09T00:43:51Z","timestamp":1126226631000},"page":"60-62","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":49,"title":["Photosensitivity and acute liver injury in myeloproliferative disorder secondary to late-onset protoporphyria caused by deletion of a ferrochelatase gene in hematopoietic cells"],"prefix":"10.1182","volume":"107","author":[{"given":"Richard G.","family":"Goodwin","sequence":"first","affiliation":[{"name":"From the Departments of Dermatology, Haematology, Pathology, Medical Biochemistry and Immunology, University Hospital of Wales, Cardiff, and School of Medicine, Cardiff University, Cardiff, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Jonathan","family":"Kell","sequence":"additional","affiliation":[{"name":"From the Departments of Dermatology, Haematology, Pathology, Medical Biochemistry and Immunology, University Hospital of Wales, Cardiff, and School of Medicine, Cardiff University, Cardiff, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Laidler","sequence":"additional","affiliation":[{"name":"From the Departments of Dermatology, Haematology, Pathology, Medical Biochemistry and Immunology, University Hospital of Wales, Cardiff, and School of Medicine, Cardiff University, Cardiff, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Colin","family":"Long","sequence":"additional","affiliation":[{"name":"From the Departments of Dermatology, Haematology, Pathology, Medical Biochemistry and Immunology, University Hospital of Wales, Cardiff, and School of Medicine, Cardiff University, Cardiff, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon D.","family":"Whatley","sequence":"additional","affiliation":[{"name":"From the Departments of Dermatology, Haematology, Pathology, Medical Biochemistry and Immunology, University Hospital of Wales, Cardiff, and School of Medicine, Cardiff University, Cardiff, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"McKinley","sequence":"additional","affiliation":[{"name":"From the Departments of Dermatology, Haematology, Pathology, Medical Biochemistry and Immunology, University Hospital of Wales, Cardiff, and School of Medicine, Cardiff University, Cardiff, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael N.","family":"Badminton","sequence":"additional","affiliation":[{"name":"From the Departments of Dermatology, Haematology, Pathology, Medical Biochemistry and Immunology, University Hospital of Wales, Cardiff, and School of Medicine, Cardiff University, Cardiff, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan K.","family":"Burnett","sequence":"additional","affiliation":[{"name":"From the Departments of Dermatology, Haematology, Pathology, Medical Biochemistry and Immunology, University Hospital of Wales, Cardiff, and School of Medicine, Cardiff University, Cardiff, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geraint T.","family":"Williams","sequence":"additional","affiliation":[{"name":"From the Departments of Dermatology, Haematology, Pathology, Medical Biochemistry and Immunology, University Hospital of Wales, Cardiff, and School of Medicine, Cardiff University, Cardiff, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George H.","family":"Elder","sequence":"additional","affiliation":[{"name":"From the Departments of Dermatology, Haematology, Pathology, Medical Biochemistry and Immunology, University Hospital of Wales, Cardiff, and School of Medicine, Cardiff University, Cardiff, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111703554016200_REF1","doi-asserted-by":"crossref","unstructured":"Todd DJ. Erythropoietic protoporphyria. Brit J Dermatol. 1994;131: 751-766.","DOI":"10.1111\/j.1365-2133.1994.tb08577.x"},{"key":"2019111703554016200_REF2","doi-asserted-by":"crossref","unstructured":"Gouya L, Puy H, Robreau AM, et al. The penetrance of autosomal dominant erythropoietic protoporphyria is modulated by expression of wildtype FECH. Nat Genet. 2002;30: 27-30.","DOI":"10.1038\/ng809"},{"key":"2019111703554016200_REF3","doi-asserted-by":"crossref","unstructured":"Risheg H, Chen FP, Bloomer JR. Genotype determinants of phenotype in North American patients with erythropoietic protoporphyria. Mol Genet Metab. 2003;80: 196-206.","DOI":"10.1016\/j.ymgme.2003.07.001"},{"key":"2019111703554016200_REF4","doi-asserted-by":"crossref","unstructured":"Whatley SD, Mason NG, Khan M, et al. Autosomal recessive erythropoietic protoporphyria in the United Kingdom: prevalence and relationship to liver disease. J Med Genet. 2004;41: e105.","DOI":"10.1136\/jmg.2003.016121"},{"key":"2019111703554016200_REF5","doi-asserted-by":"crossref","unstructured":"Bloomer JR. The liver in protoporphyria. Hepatol. 1988;8: 402-407.","DOI":"10.1002\/hep.1840080235"},{"key":"2019111703554016200_REF6","unstructured":"Meerman L. Erythropoietic protoporphyria: an overview with emphasis on the liver. Scand J Gastroenterol. 2000;35(suppl 232): 79-85."},{"key":"2019111703554016200_REF7","doi-asserted-by":"crossref","unstructured":"Lim HW, Cooper D, Sassa S, et al. Photosensitivity, abnormal porphyrin profile, and sideroblastic anemia. J Am Acad Dermatol. 1992;27: 287-292.","DOI":"10.1016\/0190-9622(92)70182-F"},{"key":"2019111703554016200_REF8","unstructured":"Shirota T, Yamamoto H, Hayashi S, et al. Myelodysplastic syndrome terminating in erythropoietic protoporphyria after 15 years of aplastic anemia. Int J Hematol. 2000;72: 44-47."},{"key":"2019111703554016200_REF9","doi-asserted-by":"crossref","unstructured":"Aplin C, Whatley SD, Thompson P, et al. Late-onset erythropoietic porphyria caused by a chromosome 18q deletion in erythroid cells. J Invest Dermatol. 2001;117: 1647-1649.","DOI":"10.1046\/j.0022-202x.2001.01560.x"},{"key":"2019111703554016200_REF10","unstructured":"Spann CT, Tok J, Nimer S, Zug K, Deleo V. Adult onset erythropoietic protoporphyria in association with myelodysplastic syndrome [abstract]. American Academy of Dermatology Annual Meeting, New Orleans, LA, February 22-27, 2002."},{"key":"2019111703554016200_REF11","doi-asserted-by":"crossref","unstructured":"Yau SC, Bobrow M, Mathew CG, Abbs SJ. Accurate diagnosis of carriers of deletions and duplications in Duchenne\/Becker muscular dystrophy by fluorescent dosage analysis. J Med Genet. 1996;33: 550-558.","DOI":"10.1136\/jmg.33.7.550"},{"key":"2019111703554016200_REF12","doi-asserted-by":"crossref","unstructured":"Deacon AC, Elder GH. Front line tests for the investigation of suspected porphyria. J Clin Pathol. 2001;54: 500-507.","DOI":"10.1136\/jcp.54.7.500"},{"key":"2019111703554016200_REF13","unstructured":"Cox TM. Protoporphyria. In: The Porphyrin Handbook: Medical Aspects of Porphyrias. Vol 14. Kadish KM, Smith KM, Guilard R, eds. Amsterdam, the Netherlands: Academic Press. 2003; 121-150."},{"key":"2019111703554016200_REF14","doi-asserted-by":"crossref","unstructured":"Steensma DP, Higgs DR, Fisher CA, Gibbons RJ. Acquired somatic ATRX mutations in myelodysplastic syndrome associated with alpha thalassemia (ATMDS) convey a more severe hematological phenotype than germline ATRX mutations. Blood. 2004;103: 2019-2026.","DOI":"10.1182\/blood-2003-09-3360"},{"key":"2019111703554016200_REF15","unstructured":"Sassa S, Akagi R, Nishitani C, Harigae H, Furiyama K. Late-onset porphyrias: what are they? Cell Mol Biol (Noisy-le-grand). 2002;48: 97-101."},{"key":"2019111703554016200_REF16","doi-asserted-by":"crossref","unstructured":"Avner DL, Lee RG, Berenson MM. Protoporphyrin-induced cholestasis in the isolated in situ perfused rat liver. J Clin Invest. 1981;67: 385-394.","DOI":"10.1172\/JCI110046"},{"key":"2019111703554016200_REF17","doi-asserted-by":"crossref","unstructured":"Do KD, Banner BF, Katz E, Szymanski IO, Bonkovsky HL. Benefits of chronic plasmapheresis and intravenous heme-albumin in erythropoietic protoporphyria after orthotopic liver transplantation. Transplantation. 2002;73: 469-472.","DOI":"10.1097\/00007890-200202150-00024"},{"key":"2019111703554016200_REF18","doi-asserted-by":"crossref","unstructured":"Dellon ES, Szczepiorkowski ZM, Dzik WH, et al. Treatment of recurrent allograft dysfunction with intravenous hematin after liver transplantation for erythropoietic protoporphyria. Transplantation. 2002;73: 911-915.","DOI":"10.1097\/00007890-200203270-00014"},{"key":"2019111703554016200_REF19","doi-asserted-by":"crossref","unstructured":"Bench AJ, Nacheva EP, Champion KM, Green AR. Molecular genetics and cytogentics of myeloproliferative disorders. Baillieres Clin Haematol. 1998;11: 819-848.","DOI":"10.1016\/S0950-3536(98)80041-3"},{"key":"2019111703554016200_REF20","doi-asserted-by":"crossref","unstructured":"Maeck L, Haase D, Schoch C, Hiddemann W, Alves F. Genetic instability in myelodysplastic syndrome: detection of microsatellite instability and loss of heterozygosity in bone marrow samples with karyotype alterations. Br J Haematol. 2000;109: 842-846.","DOI":"10.1046\/j.1365-2141.2000.02088.x"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/107\/1\/60\/1278411\/zh800106000060.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/107\/1\/60\/1278411\/zh800106000060.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,17]],"date-time":"2019-11-17T08:55:55Z","timestamp":1573980955000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/107\/1\/60\/21708\/Photosensitivity-and-acute-liver-injury-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1,1]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2004-12-4939","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,1,1]]}}}